Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2023.

Библиографические подробности
Главный автор:	Tabassum, Nadira
Другие авторы:	Yasmin, Hasina
Формат:	Диссертация
Язык:	English
Опубликовано:	Brac University 2024
Предметы:	Pharmacovigilance Alzheimer disease Dementia Rhabdomyolysis Alzheimer's disease
Online-ссылка:	http://hdl.handle.net/10361/22868

Схожие документы

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
по: Karmaker, Swastika
Опубликовано: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
по: Mahee, Sadique Abdal
Опубликовано: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
по: Shehab, Habibul Mohsin
Опубликовано: (2024)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
по: Jahan, Nusrat
Опубликовано: (2023)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
по: Bakar, Osama Bin Abu
Опубликовано: (2024)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
по: Ishrat, Nowshin
Опубликовано: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
по: Alim, Abdul
Опубликовано: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
по: Chowdhury, Sariya Uzrat
Опубликовано: (2022)

Role of protein’s and future treatment options for Alzheimer’s Disease
по: Islam, Md. Irfath
Опубликовано: (2023)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
по: Saha, Bithi Rani
Опубликовано: (2023)

Alzheimer's disease and marriage : an intimate account /
по: Wright, Lore K.
Опубликовано: (1993)

Gene editing for neurodegenerative diseases-A review
по: Sharna, Anika Islam
Опубликовано: (2023)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
по: Hassan, Md. Muhtaz
Опубликовано: (2020)

Emerging therapies of Alzheimer’s disease: a comprehensive review
по: Tasin, Md Abtahi
Опубликовано: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
по: Aziz, Farhin
Опубликовано: (2019)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
по: Tamanna, Mst. Taskia
Опубликовано: (2023)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
по: Afra, Sumaiya
Опубликовано: (2022)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
по: Tasneem, Sadia
Опубликовано: (2021)

Marine compounds in the treatment of Alzheimer’s disease
по: Parveen, Sanjana
Опубликовано: (2022)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
по: Halim, Rabea
Опубликовано: (2022)

An ambient assisted living system for Alzheimer’s patients
по: Abedin, Minhajul, и др.
Опубликовано: (2023)

Exploring Alzheimer's disease prediction with XAI in various neural network models
по: Rahman, Quazi Ashikur, и др.
Опубликовано: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
по: Aana, Afsara Sumon
Опубликовано: (2021)

Epigenetic dysregulation in neurodegenerative diseases and potential treatment
по: Mostofa, Golam
Опубликовано: (2022)

A review on adult neurogenesis in Alzheimer’s disease
по: Akter, Moriam
Опубликовано: (2022)

Potential treatments for epigenetic dysregulation in neurological diseases
по: Zaman, Rubaiyat
Опубликовано: (2024)

Federated GAN based biomedical image augmentation and classification for Alzheimer’s disease
по: Roy, Aditya, и др.
Опубликовано: (2023)

Mini-mental state examination in non-hospitalized post covid patients to identify cognitive decline
по: Tanjum, Silvia
Опубликовано: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
по: Dey, Manashi
Опубликовано: (2024)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
по: Haque, Mushfiqul
Опубликовано: (2019)

Role of circular RNA in neurological disease
по: Salsabil, Labiba
Опубликовано: (2024)

An efficient deep learning approach for detecting Alzheimer’s disease using brain images
по: Sani, Mehedi Hasan, и др.
Опубликовано: (2022)

Status of cognitive decline in post covid-19 Bangladeshi patients
по: Bapan, Pranta Saha
Опубликовано: (2024)

Design and evaluation of convolutional neural network for detection of Alzheimer’s disease using MRI data
по: Mahbub, Riasat, и др.
Опубликовано: (2022)

Anti-alzheimer and antioxidant activity of celastrus paniculatus seed
по: Alam, Badrul, и др.
Опубликовано: (2016)

Skeleton /
по: Parkin, Peter

Detection of alzheimer's disease using deep learning
по: Hasan, Mahmudul, и др.
Опубликовано: (2021)

A review on interrelation among post-authorisation study, regulatory action and pharmacogenetics in pharmacovigilance
по: Nusrat, Tanzina
Опубликовано: (2019)

Early prediction of Alzheimer's disease using convolutional neural network
по: Abed, Mahjabeen Tamanna, и др.
Опубликовано: (2020)

Antihypertensive drugs and risk of cancer: A pharmacovigilance study
по: Rahman, Ahadina
Опубликовано: (2018)